Viemed Healthcare ROA 2018-2019 | VMD
Current and historical return on assets (ROA) values for Viemed Healthcare (VMD) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Viemed Healthcare ROA for the three months ending September 30, 2019 was 15.19%.
| Viemed Healthcare ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-09-30 | $0.01B | $0.08B | 15.15% |
| 2019-06-30 | $0.01B | $0.07B | 19.57% |
| 2019-03-31 | $0.01B | $0.06B | 31.86% |
| 2018-12-31 | $0.01B | $0.05B | 66.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.216B | $0.065B |
| Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $159.317B | 22.01 |
| Abbott Laboratories (ABT) | United States | $156.119B | 28.48 |
| Stryker (SYK) | United States | $78.360B | 26.35 |
| Boston Scientific (BSX) | United States | $60.213B | 28.42 |
| Baxter (BAX) | United States | $45.945B | 27.86 |
| Essilor Luxottica (ESLOY) | France | $34.669B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.600B | 19.20 |
| Lonza Group Ag (LZAGY) | Switzerland | $28.331B | 0.00 |
| Terumo (TRUMY) | Japan | $27.798B | 34.69 |
| Coloplast (CLPBY) | Denmark | $27.302B | 42.13 |
| ResMed (RMD) | United States | $23.111B | 42.63 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.536B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $19.930B | 0.00 |
| Insulet (PODD) | United States | $11.836B | 563.12 |
| Bio-Rad Laboratories (BIO) | United States | $11.366B | 54.56 |
| Canopy Growth (CGC) | Canada | $8.470B | 0.00 |
| Perrigo (PRGO) | Ireland | $8.100B | 15.10 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.790B | 22.90 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.357B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $6.158B | 31.81 |
| Haemonetics (HAE) | United States | $5.880B | 39.73 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| NuVasive (NUVA) | United States | $4.131B | 32.53 |
| ICU Medical (ICUI) | United States | $3.896B | 25.40 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.868B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.680B | 0.00 |
| Neogen (NEOG) | United States | $3.677B | 61.18 |
| Quidel (QDEL) | United States | $3.119B | 29.60 |
| Agios Pharmaceuticals (AGIO) | United States | $3.035B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.590B | 58.45 |
| Aurora Cannabis (ACB) | Canada | $2.342B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.844B | 0.00 |
| AtriCure (ATRC) | United States | $1.453B | 0.00 |
| InMode (INMD) | Israel | $1.430B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.397B | 0.00 |
| Aphria (APHA) | $1.311B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.218B | 24.35 |
| NanoString Technologies (NSTG) | United States | $1.102B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.058B | 19.82 |
| PetIQ (PETQ) | United States | $0.884B | 21.56 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.814B | 31.18 |
| Lantheus Holdings (LNTH) | United States | $0.740B | 18.49 |
| LeMaitre Vascular (LMAT) | United States | $0.740B | 41.57 |
| Omeros (OMER) | United States | $0.736B | 0.00 |
| Quanterix (QTRX) | United States | $0.693B | 0.00 |
| Cerus (CERS) | United States | $0.589B | 0.00 |
| MacroGenics (MGNX) | United States | $0.567B | 0.00 |
| Surmodics (SRDX) | United States | $0.561B | 58.15 |
| Organigram Holdings (OGI) | Canada | $0.531B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.515B | 30.93 |
| HEXO (HEXO) | $0.484B | 0.00 | |
| Meridian Bioscience (VIVO) | United States | $0.428B | 14.71 |
| Utah Medical Products (UTMD) | United States | $0.392B | 28.40 |
| Owens & Minor (OMI) | United States | $0.364B | 13.47 |
| Zynex (ZYXI) | United States | $0.346B | 39.19 |
| BioLife Solutions (BLFS) | United States | $0.325B | 132.50 |
| Bovie Medical (APYX) | United States | $0.286B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.272B | 0.00 |
| Female Health (VERU) | United States | $0.267B | 0.00 |
| Vapotherm (VAPO) | United States | $0.252B | 0.00 |
| United Health Products (UEEC) | United States | $0.233B | 0.00 |
| Repro-Med Systems (KRMD) | United States | $0.215B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.188B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.182B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.175B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.171B | 861.00 |
| Cytosorbents (CTSO) | United States | $0.151B | 0.00 |
| Fonar (FONR) | United States | $0.136B | 9.59 |
| Chimerix (CMRX) | United States | $0.127B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| United-Guardian (UG) | United States | $0.090B | 22.83 |
| MRI Interventions (MRIC) | United States | $0.087B | 0.00 |
| Surface Oncology (SURF) | United States | $0.087B | 0.00 |
| Nephros (NEPH) | United States | $0.079B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.070B | 0.00 |
| FSD PHARMA INC (HUGE) | $0.046B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.036B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.025B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.025B | 0.00 |
| Senestech (SNES) | United States | $0.017B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.008B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.006B | 0.00 |
| Myomo (MYO) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
